Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2000, p. 3441-3443, Vol. 44, No. 12
Department of Molecular and Cell Biology,
University of California, Berkeley, California,1
and Department of Pathology, Microbiology Section,
University of Verona, Verona, Italy2
Received 30 May 2000/Returned for modification 12 July
2000/Accepted 11 September 2000
Immunoblotting with antibody against AcrA, an obligatory component
of the AcrAB multidrug efflux system, showed that this protein was
overexpressed by
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
High-Level Fluoroquinolone-Resistant Clinical
Isolates of Escherichia coli Overproduce Multidrug
Efflux Protein AcrA
170% in 9 of 10 clinical isolates of
Esherichia coli with high-level ciprofloxacin resistance
(MICs,
32 µg/ml) but not in any of the 15 isolates for which the
MIC was
1 µg/ml.
*
Corresponding author. Mailing address: Department of
Molecular and Cell Biology, Room 229 Stanley Hall, University of
California, Berkeley, CA 94720-3206. Phone: (510) 642-2027. Fax: (510)
643-9290. E-mail: nhiroshi{at}uclink4.berkeley.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |